A dual efficacy-implementation trial of a novel mobile application for childhood nephrotic syndrome management: the UrApp for childhood nephrotic syndrome management pilot study protocol (UrApp pilot study)
Chia-shi Wang(Emory University), Larry A. Greenbaum(Emory University), Rachel E. Patzer(Regenstrief Institute), Amira Al‐Uzri(Oregon Health & Science University), Cam Escoffery(Emory University), Courtney McCracken(Emory University), Diana Ross(Emory University), Michelle N. Rheault(Columbia University Irving Medical Center)
Cited by 2
Related Papers
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
|Kidney International|2013|350
Management of Childhood Onset Nephrotic Syndrome
|PEDIATRICS|2009|312
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|255